論文

査読有り 筆頭著者 責任著者
2020年11月4日

Can irritable bowel syndrome be detected by ultrasound?

Drug discoveries & therapeutics
  • Yohei Okawa

14
5
開始ページ
213
終了ページ
217
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.5582/ddt.2020.03082

Functional gastrointestinal disease is one in which gastrointestinal symptoms persist chronically or recurrently. This disease is challenging because it does not have an organic cause that can be detected in routine laboratory tests. Among them, the symptoms of irritable bowel syndrome (IBS), which is a type of functional gastrointestinal tract disease, include abnormal bowel movements associated with abdominal pain. However, no specific test has been established to definitively diagnose these diseases, including IBS. The traditional Rome IV diagnostic criteria are used to diagnose IBS by assessing subjective symptoms. However, it has been suggested that IBS is difficult to diagnose using the Rome IV criteria among unconscious or cognitively impaired patients. It is recommended that abdominal ultrasonography be used to assess IBS with diarrhea and constipation. Previously, constipation among elderly people who ingested food orally was objectively assessed by ultrasound, and colonic fecal distribution patterns were classified in constipated patients and healthy people. Objective visualization of the large intestine was used to assess constipation. Therefore, fecal retention among adults and elderly individuals was reported using ultrasonography. It was suggested that stool retention could be confirmed by observing the hyperechoic region of the rectum. Strong hyperechoic regions with acoustic shadows in the rectum indicate the presence of hard stools, thus enabling medical workers to identify constipation. In the future, ultrasonography may be useful for diagnosing IBS in unconscious patients or those with cognitive decline.

リンク情報
DOI
https://doi.org/10.5582/ddt.2020.03082
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33116042
ID情報
  • DOI : 10.5582/ddt.2020.03082
  • PubMed ID : 33116042

エクスポート
BibTeX RIS